Should patient enrollment criteria for anti‐VEGF phase III trials be reconsidered
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-10-01
|
| Series: | Journal of Diabetes |
| Online Access: | https://doi.org/10.1111/1753-0407.13468 |